Literature DB >> 6477782

Influence of dihydralazine induced afterload reduction on systolic time intervals and echocardiography in healthy subjects.

H C Stern, J H Matthews, G G Belz.   

Abstract

The influence of a pure afterload reduction on systolic time intervals and various echocardiographic indices was assessed in six healthy volunteers, who underwent a single blind placebo controlled trial of three regimens of intravenous dihydralazine (6.25, 12.5, and 25.0 mg). Subsequently autonomic blockade (propranolol and atropine) was used to eliminate the influence of the autonomic reflex action during dosage with dihydralazine 6.25 mg. Dihydralazine increased heart rate to an extent depending on dose, decreased diastolic blood pressure, end systolic diameter, and end systolic wall stress, and enhanced fractional shortening and cardiac output. Heart rate corrected pre-ejection period was shortened and left ventricular ejection time was prolonged, whereas electromechanical systole remained virtually unchanged. Autonomic blockade eliminated dihydralazine's effect on heart rate and cardiac output; blood pressure and systolic wall stress fell appreciably, whereas dihydralazine-induced changes in the systolic time intervals were virtually unaffected. Thus the present study indicates that regardless of the autonomic reflexes heart rate corrected pre-ejection period and left ventricular ejection time, but not electromechanical systole, are highly dependent on afterload, and this effect should be considered when systolic time intervals are evaluated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477782      PMCID: PMC481656          DOI: 10.1136/hrt.52.4.435

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  17 in total

1.  The hemodynamic effects of hypotensive drugs in man. IV. 1-Hydrazinophthalazine.

Authors:  E D FREIS; J C ROSE; T F HIGGINS; F A FINNERTY; R T KELLEY; E A PARTENOPE
Journal:  Circulation       Date:  1953-08       Impact factor: 29.690

2.  Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.

Authors:  L E Teichholz; T Kreulen; M V Herman; R Gorlin
Journal:  Am J Cardiol       Date:  1976-01       Impact factor: 2.778

3.  A critical review of the systolic time intervals.

Authors:  R P Lewis; S E Rittogers; W F Froester; H Boudoulas
Journal:  Circulation       Date:  1977-08       Impact factor: 29.690

Review 4.  Vasodilator drugs in the treatment of hypertension.

Authors:  J Koch-Weser
Journal:  Arch Intern Med       Date:  1974-06

5.  Effects of atrial pacing on left ventricular performance in patients with heart disease.

Authors:  R F Leighton; S J Zaron; J L Robinson; A M Weissler
Journal:  Circulation       Date:  1969-11       Impact factor: 29.690

6.  Correlation between changes in systolic time intervals and left ventricular end-diastolic diameter after preload reduction. Non-invasive monitoring of pharmacological intervention.

Authors:  J Buch; H Egeblad; P B Hansen; H Kjaergård; S Waldorff; E Steiness
Journal:  Br Heart J       Date:  1980-12

7.  [Non-invasive studies on the cardiac effect of low digitoxin maintenance doses (author's transl)].

Authors:  G G Belz; G Riedlinger
Journal:  Z Kardiol       Date:  1980-04

8.  Effects of adrenergic receptor activation and blockade on the systolic preejection period, heart rate, and arterial pressure in man.

Authors:  W S Harris; C D Schoenfeld; A M Weissler
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

9.  Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man.

Authors:  A D Jose; R R Taylor
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

10.  Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations.

Authors:  W Grossman; E Braunwald; T Mann; L P McLaurin; L H Green
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

View more
  14 in total

1.  Noninvasive assessment of the inodilator action of amrinone in healthy man.

Authors:  C de Mey; D Enterling; G Hanft
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Influence of profuse sweating on systolic time intervals.

Authors:  G G Bely; D H Spodick
Journal:  Br Heart J       Date:  1987-06

3.  Are pre-ejection period changes specific for inotropic effects?

Authors:  P H Joubert; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Captopril in children with dilated cardiomyopathy: acute and long-term effects in a prospective study of hemodynamic and hormonal effects.

Authors:  H Stern; J Weil; T Genz; W Vogt; K Bühlmeyer
Journal:  Pediatr Cardiol       Date:  1990-01       Impact factor: 1.655

5.  The acute effects of amiloride and potassium canrenoate on digoxin-induced positive inotropism in healthy volunteers.

Authors:  J P Richter; D K Sommers; J R Snyman; S M Millard
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  Systolic time intervals in clinical pharmacology.

Authors:  Q Li; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Inotropic effects of ranitidine.

Authors:  E C Meyer; D K Sommers; M van Wyk; J C Avenant
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

8.  Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin.

Authors:  W Kirch; J Stenzel; P Dylewicz; H J Hutt; S R Santos; E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

9.  Intrinsic and reflex actions of verapamil and nifedipine: assessment in normal subjects by noninvasive techniques and autonomic blockade.

Authors:  H C Stern; J H Matthews; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Effects of atropine on human cardiac beta 1- and/or beta 2-adrenoceptor stimulation.

Authors:  Heike Bruck; Anke Ulrich; Stefan Gerlach; Joachim Radke; Otto-Erich Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-21       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.